Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2025-09-12 00:00:00 ET · period of report 2025-09-12 · accession 0001677455-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-12 | 2025-09-12 | RARE | Parschauer Karah Herdman | EVP, CLO | S - Sale | $31.17 | -2,450 | 73.3K | -3% | -$76.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-12 | S | D | 2,450 | $31.17 | 73,271 | D | — | — | (F2) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. (F1) Includes 434 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on April 30, 2025. |